top of page

Search Results

374 items found for "Chaoliang Li"

  • GPCR Weekly Whirlwind: Top Receptor Highlights from Sep 30 - Oct 6, 2024!

    ,  Andrea Vernall , et al. for their fantastic paper on Development of Putative Bivalent Dicovalent Ligands New ligands and new GPCR behaviors that produce unique drug profiles (i.e. intracellular ligands and November 14th : The Application of GPCR Ligand Kinetics to Candidate Design. November 21st : Unconventional GPCR Ligands as Drugs. December 5th : Unique Exploitable GPCR-Ligand Behaviors for Therapeutic Benefit.

  • GPCR Buzz of the Week | Sep 23 - 29, 2024

    New ligands and new GPCR behaviors that produce unique drug profiles (i.e. intracellular ligands and November 14th : The Application of GPCR Ligand Kinetics to Candidate Design. November 21st : Unconventional GPCR Ligands as Drugs. December 5th : Unique Exploitable GPCR-Ligand Behaviors for Therapeutic Benefit. 🌟 Get pumped up - the complete agenda is live; don't miss out HERE !

  • AlphaFold’s Breakthrough in GPCR Research: Revolutionizing Discovery, Yet Awaiting Experimental Proof

    for predicting G protein-coupled receptor (GPCR) structures, especially when experimental data were limited However, this method has limitations: its accuracy is heavily dependent on the availability and quality In a recent study on TAAR1, a GPCR linked to central nervous system disorders, researchers compared the synthetic compounds, limiting its utility in drug discovery involving novel drug-like molecules. Ligand discovery from a dopamine D3 receptor homology model and crystal structure.

  • 📢 Early Bird Registration Ends Tomorrow! | Sep 16 - 22, 2024

    Exclusive Deal for Scientists Residing and Working in Developing Nations If you live and work  in a developing 🌟 Exciting news - the complete agenda is live; check it out HERE ! GPCRs in Oncology and Immunology GPR37 promotes colorectal cancer against ferroptosis by reprogramming lipid metabolism via p38-SCD1 axis Methods & Updates in GPCR Research GPCRSPACE: A New GPCR Real Expanded Library Study Conformational Dynamics and Signaling in Drug Discovery Flavors of GPCR signaling bias Glucagon-like

  • Biased Agonism at the GLP-1 Receptor: A Pathway to Improved Therapeutic Outcomes

    Biased agonism is a phenomenon where different ligands acting on the same receptor trigger distinct signaling the glucagon-like peptide-1 receptor (GLP-1R). Compared to the endogenous ligand GLP-1, another endogenous ligand, oxyntomodulin, exhibits a bias towards In contrast, ligands like oxyntomodulin that preferentially activate ERK1/2 signaling interact more significantly Indeed, incretin-based drugs like Novo Nordisk's Wegovy and Eli Lilly's Zepbound are advancing diabetes

  • Transformative GPCR Insights: Unleash New Horizons in Science | Sep 9 - 15, 2024

    groundbreaking work on Positive allosteric modulation of a GPCR ternary complex Unlock Your Learning: Limited Exclusive Deal for Scientists Residing and Working in Developing Nations If you live and work  in a developing UK announced the winners of its Transforming Cancer Therapeutics grant, which focuses on developing life-changing for schizophrenia Crinetics Pharmaceuticals Announces September 2024 Inducement Grants Under Nasdaq Listing GPCR ternary complex GPCR Binders, Drugs, and more Progress on the development of Class A GPCR-biased ligands

  • Unlock the Future of GPCR Science: Breakthroughs and Courses Await | Sep 2 - Sep 8, 2024

    ., for their study on Cell swelling enhances ligand-driven β-adrenergic signaling ✨ Reserve Your seat But act fast – this offer is only available for a limited time. Not a premium member yet? Exclusive Deal for Scientists Residing and Working in Developing Nations If you live and work  in a developing through IHH Signaling GPCR Activation and Signaling Illuminating GPCR trafficking Cell swelling enhances ligand-driven in Cardiology, Endocrinology, and Taste Role of G protein coupled receptors in acute kidney injury Ligand-Dependent

  • APEX2/AUR Biosensor: A Powerful Tool for Protein Interaction and Trafficking

    advancements in the cellular biology of G protein-coupled receptors (GPCRs) about a novel biosensor shed light Therefore, it’s a great molecular tool for proximity labeling approaches in living cells. 

  • GPCR Updates: Celebrating Breakthroughs, New Course Launches Soon, and Exclusive Discounts! | Aug 26 - Sep 1, 2024

    Premium members can enjoy a 25% OFF early bird discount , but hurry - it's only available for a limited Special Offer for Scientists who work and live in developing countries If you live and work in a developing

  • Decoding GPCR Function: The Role of Mutagenesis in Rational Drug Discovery

    novel ligands for the A 2A  adenosine receptor. function and ligand-receptor interactions. However, several challenges have limited the use of mutagenesis in drug discovery. Structure-based discovery of A2A adenosine receptor ligands. Molecular determinants of ligand efficacy and potency in GPCR signaling.

  • 📢 GPCR Update: August 19-25, 2024 | Thrilling Announcement: New Pharmacology Course Dates & Exclusive Discounts Inside!

    GPCR Activation and Signaling Homodimerization of CB2 cannabinoid receptor triggered by a bivalent ligand the GPR37-mTOR-S6K1 Signaling GPCRs in Neuroscience Astrocyte Gi-GPCR signaling corrects compulsive-like

  • 📰 GPCR Weekly Buzz: Exciting Schedule Shifts for Principles of Pharmacology I & II | August 12-18, 2024

    member , you’re also unlocking over 500 minutes of exclusive, expert-led content from thought leaders like Don’t miss out on insightful resources like '   Applying Pharmacology to Drug Discovery ' and ' Advanced Sexton , Denise Wootten , et al., for their work on Isoquinoline small molecule ligands are agonists Positive Allosteric Modulators Enabling Optical Control of the M1 Receptor Isoquinoline small molecule ligands Insights into GPCR Function Monitoring GPCR conformation with GFP-inspired dyes Structural basis for the ligand

  • 📰 GPCR Buzz: August 5-11, 2024 | Top Highlights from DrGPCR University!

    GPCR University offers two live courses this fall that you won’t want to miss. 5 to 26, 2024 What You’ll Learn during the four sessions: How to measure pharmacologic activity of ligands (affinity, efficacy, co-operativity) Determining mechanisms of action for new GPCR ligands Key elements 31, 2024 What You’ll Master during the five sessions: Utilizing new cellular assays to analyze GPCR ligand behavior Predicting activity and in vivo target coverage with real-time kinetics Discovering new ligands

  • Enhancing GPCR Research Outreach | Dr GPCR University early-bird registration ends soon!

    (affinity, efficacy, co-operativity) Determining mechanisms of action for new GPCR ligands Elements and effective GPCR discovery Master advanced applications: Using new cellular assays to analyze GPCR ligand behavior Predicting activity and in vivo target coverage with real-time kinetics Discovering new ligands human G protein-coupled receptor biology and pharmacology Industry News Muscarinic drugs breathe new life into schizophrenia pipeline GPCR Dynamics Reveal Mechanisms for Drug Discovery DMS: Linking Protein

  • Dr. GPCR University registration is now open! Secure your spot now!

    Gábor Turu, and László Hunyady for their research on Functional consequences of spatial, temporal and ligand Kenakin Reading Materials Access to the private group Certificate Explore: Key metrics for assessing ligand pharmacology (affinity, efficacy, co-operativity) Mechanisms of action for new GPCR ligands Essentials for predicting activity Unique drug profiles from new ligands and GPCR behaviors GPCR Event Highlight GPCR oligomers in live cells Industry News Confo Therapeutics Announces EUR 60M Series B Financing to

  • Unlocking the Future of Medicine: Advancements in GPCR Research

    Application of this knowledge to determine the mechanism of action of new GPCR ligands. New ligands and new GPCR behaviors that produce unique drug profiles (i.e., intracellular ligands and Hosted by the Adhesion GPCR Consortium, this exciting event will occur in lively and culturally rich It is an opportunity to connect with like-minded scientists and researchers and gain valuable insights receptor subtypes Structural insights into ligand recognition, selectivity, and activation of bombesin

  • Exploring the Breakthroughs in GPCR Research

    News from July 8th to 14th, 2024 GPCR Activation and Signaling GPR116 alleviates acetaminophen-induced liver Receptor Influence of the Water Model on the Structure and Interactions of the GPR40 Protein with the Lipid Membrane and the Solvent: Rigid versus Flexible Water Models Probing the energy landscape of the lipid 2028 At Rate Of 6.5% Trevena Announces $2M Non-Dilutive Financing Tranche and Reduction in Outstanding Liabilities

  • 📰 GPCR Weekly News, July 1 to 7, 2024

    Research Computational modelling of dynamic cAMP responses to GPCR agonists for exploration of GLP-1R ligand

  • 📰 GPCR Weekly News, June 24 to 30, 2024

    Basis of MC1R Activation: Mutation-Induced Alterations in Structural Dynamics Structural insights into ligand Approach Redox-modulated SNX25 as a novel regulator of GPCR-G protein signaling from endosomes Cellular lipids Translation-independent association of mRNAs encoding protomers of the 5-HT 2A -mGlu2 receptor complex in living First R&D Milestone Tectonic bets on GPCR heart failure drug following reverse merger with Avrobio Lilly

  • Do You Believe AI Could Accelerate Drug Discovery?

    However, the impact on structure-based ligand discovery remained uncertain due to the necessity for accurately Lyu et al. prospectively docked ultra-large libraries of molecules against unrefined AF2 models of the Moreover, advanced AI models like AlphaFold3, which can predict complex protein-molecule interactions This proprietary nature limits direct access to the model and imposes a cap on daily predictions. AlphaFold2 structures guide prospective ligand discovery.

  • 📰 GPCR Weekly News, June 3 to June 9, 2024

    Jürgen Wess and Liu Liu for their study on A novel function of the M2 muscarinic receptor Drs. vivo via differential phosphorylation Increased transcriptional elongation and RNA stability of GPCR ligand -PH domain-based fluorescent reporters for visualizing phosphatidylinositol 4-phosphate dynamics in living

  • Navigating the Signaling Network: RTK and GPCR Crosstalk Uncovered

    Suchismita Roy et al. have explored how growth factors can modulate canonical G protein signaling, shedding light They employed a series of phospho-mimicking mutants and assays such as linear ion trap mass spectrometry Key findings include: Phosphorylation Hotspots: P Loop (Ser44, Ser47, Thr48): Impairs ligand-stimulated Interdomain Cleft (Ser151, Tyr154, Tyr155): Phosphorylation at Tyr154 and Tyr155 impaired ligand-stimulated C Terminus (Tyr320): Phosphorylation at Tyr320 disrupted Gβγ binding, receptor coupling, and ligand-stimulated

  • 📰 GPCR Weekly News, May 27 to June 2, 2024

    Brendan Creemer, Thomas Gardella, and Ross Cheloha for their work on Highly biased agonism for GPCR ligands Badr Sokrat is live! You can now watch podcast episodes in video format on our website. GPCR Activation and Signaling Highly biased agonism for GPCR ligands via nanobody tethering Mechanistic orientation using a neurotensin receptor 1 peptide Illuminating the neuropeptide Y4 receptor and its ligand asthma GPCR Events, Meetings, and Webinars June 2 - 7, 2024 | Chemotactic Cytokines June 4, 2024 | Live

  • Canonical chemokine receptors as scavenging “decoys”

    receptors (CKRs) that signal via Gαi and 4 official atypical chemokine receptors (ACKRs) which engage in ligand Indeed, ACKRs behave as scavenging “decoys” in order to either limit chemokines spatial availability sites, while maintaining the responsiveness of canonical G protein-coupled CKRs that bind to the same ligand inflammatory response when needed; and it may interfere with other chemokine receptors which share the ligands CKRs should be considered when evaluating the safety and therapeutic efficacy of blocking receptor-ligand

  • 📰 GPCR Weekly News, May 20 to 26, 2024

    Jacek Mokrosiński is live! Development of Selective Cannabinoid Receptor 2 Inverse Agonists Development of Putative Bivalent Dicovalent Ligands prospects, and pathophysiological perspectives Structural and Molecular Insights into GPCR Function Bilayer lipids modulate ligand binding to atypical chemokine receptor 3 Industry News New cannabinoid CB1 receptor | ENDO 2024 NEW June 3 - 6, 2024 | BIO 2024 June 2 - 7, 2024 | Chemotactic Cytokines June 4, 2024 | Live

  • Adhesion GPCR Consortium Newsletter - May 2024

    To my surprise and delight, the neurexins happened to be ligands for one isoform of the Latrophilins. AB: The next workshop will likely bring together some of the hottest adhesion GPCR research going on community, added to the fact that this will all take place for the first time in a developing country like The food: While in Mexico, eat like one. The diversity is humongous. What mariachi song are you most likely to shout along to at 3 AM?

  • Extracellular signal-regulated kinases – a potential pathway for GPCR-targeted drug discovery

    Initially, the activation of small GTPases like RAS leads to the activation of the MAP kinase kinase

  • 📰 GPCR Weekly News, May 13 to 19, 2024

    Azietaku for his first contributor article on Illuminating GPCR Research: FRET and BRET-Based Sensors Shed Light Lyu, Brian Shoichet, Bryan Roth, et al. for their research on AlphaFold2 structures guide prospective ligand Arthur Christopoulos is now live, titled "A Brief History of Allosteric Modulators."  of the Prototypic G Protein-Coupled Adenosine A2A Receptor AlphaFold2 structures guide prospective ligand SLAS Europe 2024 Conference and Exhibition June 2 - 7, 2024 | Chemotactic Cytokines NEW June 4, 2024 | Live

bottom of page